A major industrial project near Hattiesburg is moving into its next stage of development as leaders work to attract a large ...
A long-term construction project aimed at reducing congestion and improving safety at the Highway 25 and U.S. 101 interchange ...
The failed Oracle-Blue Owl data center deal likely pricked the credit-driven AI infrastructure bubble, and thus the AI bubble, and consequently the S&P500 bubble. This is likely the Phase one of the ...
CHARLESTON, S.C. (WCSC) — Construction will begin on the first phase of Charleston’s Lowline project, a multi-use pedestrian pathway that will repurpose an old rail bed similar to the West Ashley ...
CHARLESTON, S.C. (WCBD) – Charleston city leaders invited partners and attendees to kick off construction for the first phase of a long-awaited transportation project on the peninsula. For over a ...
CHARLESTON, S.C. (WCBD) – Charleston city leaders and project partners are set to gather Friday, breaking ground on a new greenway that will improve mobility from Charleston to surrounding areas.
Fluor and JGC said Monday they had handed over LNG Canada's second production train, bringing the Shell-led project's capacity to 14 million tons a year. Image by MikeMareen via iStock Fluor Corp and ...
President Donald Trump, joined by Chinese Vice Premier Liu He, sign the U.S.-China Phase One trade agreement in 2020. (White House photo) Farm organizations are warning the Trump administration that ...
Hillwood Communities has broken ground near the Alliance area on its largest master-planned community to date. The Perot-owned company is embarking on phase one of Landmark, a $10 billion, 3,200-acre ...
Enbridge plans to invest approximately $1.4 billion in the project, adding 150 kbpd of capacity to the Mainline system and 100 kbpd to the FSP. The company expects the new capacity to come online in ...
Angiopoietin-like protein 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases. ANGPTL3 loss-of-function genetic variants are associated with decreased levels of low-density lipoprotein ...
AstraZeneca has ended work on one of its potential drugs for fatty liver disease after viewing disappointing data from a phase 2 study. The U.K.-based pharma had been evaluating the antisense ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results